Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

TransMedics Group Inc (TMDX)

Healthcare Medical Devices
76.50 $
+0.5% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns TransMedics Group Inc (TMDX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.7% of the shares are freely tradable; institutional investors hold 108.9%.

Ownership Structure

Institutional ownership
108.9%
Insiders
3.4%
Float
96.7%
Short % of float
34.7%
Shares Outstanding
35Mio.

Largest Shareholders

Institutions

Institutions TMDX
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.32 5,293,331 -1.9 03/31/2026
FMR Inc 14.75 5,096,243 +0.4 03/31/2026
Vanguard Group Inc 10.43 3,605,279 +0.0 12/31/2025
Vanguard Portfolio Management, LLC 5.55 1,919,535 +0.0 03/31/2026
Vanguard Capital Management, LLC 4.28 1,478,152 +0.0 03/31/2026
State Street Corp 3.82 1,319,479 +3.5 03/31/2026
Amvescap Plc. 3.00 1,037,974 +51.6 03/31/2026
UBS Asset Mgmt Americas Inc 2.72 939,523 -5.8 03/31/2026

Funds

Funds TMDX
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.00 2,073,206 +0.0 05/29/2026
Vanguard Total Stock Mkt Idx Inv 3.01 1,040,038 +0.3 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
10. Jul 2026 Corcoran Nicholas See remarks Other 11,727 0.00
10. Jul 2026 Hernandez Gerardo Chief Financial Officer Other 17,246 0.00
10. Jul 2026 Hassanein Waleed H President & CEO Other 49,669 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?